Sorry, this course has expired and is no longer available.
Aspirin may be the most common anti-platelet agent in use, but is it the safest? For decades, Aspirin has been used prophylactically, yet research is starting to show that there is no place for aspirin in stroke prevention. Navigating the minefield of anti-platelet agents can be confusing, and keeping up with current research can be hard. So let Dr Jenny Gowan guide you through the latest information on anti-platelets, and allow her to dissolve your confusion.
Jenny is a practicing pharmacist, a Teaching Associate at Monash University and Clinical Associate at RMIT university . She is a current member of the PSA Branch committee, Editorial Board Member of AUS-DI (Drug information), Guidelines Committee for the National Asthma Council Australian Asthma Handbook, and RACGP Silver book for Aged Care .
Jenny is an accredited consultant pharmacist, and conducts her own company focussing on medication reviews in the home and Aged Care Facilities as well as Quality Use of Medicine consultancy. She works regularly in community pharmacy plus sessions in a GP clinic at a Community Health Centre. Jenny has published over 380 educational articles and presents hundreds of talks annually.
In 2010 Jenny received the Sanofi-Aventis award by the University of Sydney, in 2013, PSA Australian Pharmacist of the Year and 2016 Jenny was the AACP-MIMs Consultant Pharmacist of the Year. See Educator Profile